多囊肾病与痴呆风险显著相关
本研究基于倾向性评分1:1匹配的队列,纳入4,229例≥20岁多囊肾病(PKD)患者与对照比较神经退行性疾病风险。PKD患者痴呆发病密度为4.31/1000人年,对照组为2.50/1000人年,校正后痴呆风险增加2.04倍,帕金森病风险增加1.78倍。
要点
- PKD患者痴呆风险较对照增加2.04倍(aHR 2.04,95%CI 1.46-2.85)。
- PKD患者早老性痴呆/AD风险aHR 2.71(95%CI 1.08-6.75),血管性痴呆无显著差异。
- PKD患者帕金森病风险增加1.78倍(95%CI 1.14-2.79)。
核心结论
- PKD患者痴呆和帕金森病风险显著高于无PKD的匹配对照。
- 临床实践中应关注PKD患者的神经退行性疾病风险。
研究设计与样本
- PKD队列纳入4,229例≥20岁确诊PKD患者。
- 对照队列按倾向性评分1:1匹配选取无PKD、痴呆或帕金森病病史的≥20岁参与者。
主要发现
- 痴呆发病密度PKD组4.31/1000人年,对照组2.50/1000人年。
- 校正后痴呆风险aHR 2.04(95%CI 1.46-2.85)。
- AD及早老性痴呆aHR 2.71(95%CI 1.08-6.75),血管性痴呆aHR 0.90(95%CI 0.43-1.87)。
- 帕金森病风险增加1.78倍(95%CI 1.14-2.79)。
关键数值与推荐
- 痴呆风险aHR 2.04(95%CI 1.46-2.85)。
- AD及早老性痴呆aHR 2.71(95%CI 1.08-6.75)。
- 血管性痴呆aHR 0.90(95%CI 0.43-1.87)。
- 帕金森病风险增加1.78倍(95%CI 1.14-2.79)。
临床怎么用
- 对PKD患者应警惕痴呆和帕金森病风险,必要时进行认知与运动功能评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Data on the risk of neurodegenerative diseases, including Alzheimer disease (AD) and Parkinson disease (PD), in patients with polycystic kidney disease (PKD) are lacking. METHODS: A total of 4,229 patients who were aged ≥20 years and had received a diagnosis of PKD were included in the PKD cohort. For each PKD case identified, 1 participant aged ≥20 years without a history of PKD, dementia, or PD was selected from the comparison cohort. For each patient with PKD, the corresponding controls were selected 1:1 on the basis of the nearest propensity score calculated using logistic regression. RESULTS: The incidence density rates of dementia were 4.31 and 2.50 per 1,000 person-years in the PKD and control cohorts, respectively. A 2.04-fold higher risk of dementia was observed in patients with PKD than in controls (adjusted hazard ratio [aHR] 2.04; 95% confidence interval [CI] 1.46-2.85). Regarding the risk of different dementia subtypes, including AD and vascular dementia (VaD), the aHR for AD and presenile dementia was 2.71 (95% CI 1.08-6.75) and that for VaD was 0.90 (95% CI 0.43-1.87) in patients with PKD compared with controls, after adjustment for age, sex, and comorbidities. Compared with controls, the risk of PD increased by 1.78-fold (95% CI 1.14-2.79) in patients with PKD. CONCLUSIONS: In clinical practice, health care professionals should be aware of the risk of neurodegenerative diseases in patients with PKD.
引用
- Yu TM, Chuang YW, Sun KT, et al. Polycystic kidney disease is significantly associated with dementia risk. Neurology. 2017. PMID: 28855402. doi:10.1212/WNL.0000000000004434
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。